Current News

PEI to distribute Venefit™ in the Irish market

PEI is delighted to announce that it has partnered with Covidien / Medtronic to distribute its innovative range of targeted endovenous therapy products in the Irish market.

Covidien / Medtronic is passionately committed to the development and commercialisation of innovative technologies aimed at treating Chronic Venous Insufficiency (CVI). In recent years, treatment options for CVI have advanced beyond invasive procedures like vein stripping and ligation. With theses new soloutions, patients experience less pain and bruising, and a faster recovery period compared to laser ablation. 

Venefit™ Targeted Endovenous Therapy is a minimally invasive treatment for varicose veins and Chronic Venous Insufficiency (CVI) in which a vein specialist inserts a Covidien ClosureFast™ endovenous radiofrequency ablation (RFA) catheter to collapse and close enlarged leg veins. After the vein is sealed shut, blood then naturally re-routes to healthy veins.

The Venefit™ Procedure: What to Expect
The ClosureFast™ catheter is inserted into the vein through a tiny incision below the knee. Guided by ultrasound imaging, the physician treats a 7 cm segment of vein with a 20-second burst of radiofrequency energy, causing the vessel to shrink around the catheter. The physician withdraws the catheter, treating each segment until the entire length of the vein has been sealed. An average 45 cm length vein can be treated in this manner in just three to five minutes.

Unlike painful vein stripping surgery or laser ablation, the catheter delivers uniform, consistent heat to each segment and temperatures do not exceed 120° C.1As a result, the Venefit™ procedure causes less bruising and allows for rapid patient relief and recovery.2 The Venefit™ procedure is commonly performed in a clinic or same-day hospital setting.


The Venefit™ Procedure Advantage:

Minimally Invasive
The Venefit™ procedure eliminates the need for groin surgery and general anesthesia. The procedure also results in little to no scarring and is generally performed using local anesthesia in a vein specialist’s office or an outpatient surgical facility.

Less Pain, Less Bruising, Faster Recovery
The 2009 RECOVERY Study compared the experience of patients treated with the ClosureFast catheter and those treated with the 980 nm laser. The study demonstrated:

• Less pain, bruising and complications with the ClosureFast™ catheter2
• Up to four times faster improvement in patients’ quality of life with the ClosureFast™ catheter versus laser based on a quality of life questionnaire2
Other studies have shown that patients receiving the Venefit™ procedure return to normal activity and work significantly faster than those undergoing vein stripping.3

Positive Clinical Outcomes
The ClosureFast catheter has been shown in a prospective, international multicenter study to be 93% effective at three years using Kaplan Meier analysis.4

The Venefit™ procedure is performed as a medical necessity as diagnosed by a trained vein specialist. It is not designed to address spider veins or cosmetic issues. However, the successful treatment of CVI using the Venefit™ procedure can produce cosmetic improvements.

If you would like more information, please contact Sinéad McCluskey, Director of Commercial Innovations (mccluskeys@pei.ie) or Judi O'Malley, Vascular Clinical Sales Specialist (omalleyj@pei.ie) or call PEI at +353 1 4196900.


November 2019
MTWTFSS
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 1
2 3 4 5 6 7 8

External Links